Le Lézard
Classified in: Health, Business
Subjects: SCZ, FVT

COMPLIMENTARY MEDICARE WEBINAR OFFERED BY EAST TEXAS PHYSICIAN GROUPS


Seniors Can Learn About their Medicare Options from Home

TEXARKANA and LONGVIEW, Texas, Oct. 20, 2022 /PRNewswire/ -- Seniors in East Texas who are aging into Medicare or want to explore their options for 2023 can attend a virtual seminar from the comfort of their own homes. LiveWell Senior Care Advantage is offering a Virtual Medicare Shop & Compare Expo,10 a.m. to 12 p.m., Wednesday, Oct. 26, 2022.

The webinar is an excellent opportunity for seniors to learn about their Medicare options. Registration is desired, but not required. To register: LiveWellSeniorCareAdvantage.com.

The webinar will include several sessions, including a physician panel entitled "The Benefits of Value-Based Healthcare;" Medicare 101 sessions by independent, licensed brokers; as well as insurance company presentations. The event is hosted by LiveWell Senior Care Advantage, a program offered by the Collom and Carney Clinic and the Diagnostic Clinic of Longview.

Don't worry if you miss the live webinar. You can still watch the Medicare information program online at LiveWellSeniorCareAdvantage.com.

About LiveWell Senior Care Advantage

LiveWell Senior Care Advantage is not a new Medicare Advantage plan. Rather, it is a collaborative approach to care delivery that focuses on preventive care and providing care coordination resources. This program is open to senior patients of the Collom and Carney Clinic and the Diagnostic Clinic of Longview. More information about LiveWell Senior Care Advantage program and Medicare informational resources are available at LiveWellSeniorCareAdvantage.com.

SOURCE LiveWell Senior Care Advantage


These press releases may also interest you

at 04:09
A news report from China Daily: The 2024 ZGC Forum in Beijing showcased a wide range of latest technological innovations. The event ran from April 25 to 29 and comprised 128 activities, including forums and conferences, technology exchanges,...

at 04:05
Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , disclosed today that under the...

at 03:38
Preparations for the planned phase 2b study continue according to plan after the completed Type C meeting with the FDA, strengthened by the fact that the median time to progression with fostrox + Lenvima increased to 7 months. January ? March...

at 03:05
The European Academy of Allergy and Clinical...

at 03:00
BioWorldtm published by  Clarivate Plc , a leading global provider of transformative intelligence, explores the growing investment in CAR T therapy development in mainland China in a new series titled "China's CAR T market comes of age." The report...

at 03:00
SynOx Therapeutics Limited ("SynOx" or the "Company"), the late-stage clinical biopharmaceutical company developing emactuzumab...



News published on and distributed by: